Healixa Announces Major Milestone Towards Commercialization Of Its Global AquaDuct Product
Healixa Announces Major Milestone Towards Commercialization Of Its Global AquaDuct Product
Healixa, Inc. (OTC:EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, today announced that as a result of successful pre-commercialization efforts, it has achieved a first-of-its-kind functional milestone for its thermal deposition water harvesting technology which is now capable of continuous water production. Healixa will also be providing commercialization updates and technology demonstrations to international government representatives, non-government organizations (NGOs) and other industry participants during an invite-only onsite tour of its development facility in South Carolina during the first quarter of 2023.
Global AquaDuct, Healixa's proprietary atmospheric water harvesting ("AWH") technology, can produce potable water directly from the earth's atmosphere by leveraging multiple advancements including a novel thermal deposition technology. Healixa's AWH technology directly addresses challenges that have previously stifled adoption of atmospheric water solutions, specifically delivering substantially improved operational performance including energy efficiency, no relative humidity dependency, and substantial reliable yields. To date, Healixa has already received over $75,000,000 in order indications.
"Healixa has achieved the latest milestone in its multi-year R&D and commercialization program for its unique Global AquaDuct AWH solution having exceeded all our internal development requirements and reaching the Minimum Viable Product (MVP) stage. As we quickly advance our commercialization efforts in 2023, we are especially excited to demonstrate Global AquaDuct MVP to select end users," commented Ian Parker, Chairman and CEO of Healixa. "On behalf of our management team, directors and advisory board, we wish to acknowledge the outstanding work and dedication of our engineering teams and manufacturing partners who supported us and look forward to doing our part to help address the growing global water scarcity crisis."
Healixa, Inc. (OTC:EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, today announced that as a result of successful pre-commercialization efforts, it has achieved a first-of-its-kind functional milestone for its thermal deposition water harvesting technology which is now capable of continuous water production. Healixa will also be providing commercialization updates and technology demonstrations to international government representatives, non-government organizations (NGOs) and other industry participants during an invite-only onsite tour of its development facility in South Carolina during the first quarter of 2023.
海力善股份有限公司 (OTC: EMOR) (「Healixa」或「公司」) 是一家致力於在健康科技、清潔水和綠色科技產業中建立和取得創新和顛覆性技術的科技公司,今天宣布,由於成功的商業化前努力,為其熱沉積水收穫技術取得了同類首個功能里程碑,現已成為可持續生產的水。在 2023 年第一季度,Healixa 還將為國際政府代表、非政府組織(NGO)和其他行業參與者提供商業化更新和技術示範,參觀其位於南卡羅來納州的開發設施。
Global AquaDuct, Healixa's proprietary atmospheric water harvesting ("AWH") technology, can produce potable water directly from the earth's atmosphere by leveraging multiple advancements including a novel thermal deposition technology. Healixa's AWH technology directly addresses challenges that have previously stifled adoption of atmospheric water solutions, specifically delivering substantially improved operational performance including energy efficiency, no relative humidity dependency, and substantial reliable yields. To date, Healixa has already received over $75,000,000 in order indications.
Global Aquaduct 是 Healixa 專有的大氣水收集 (「AWH」) 技術,可利用包括新型熱沉積技術在內的多項進步,直接從地球大氣中生產飲用水。Healixa 的 AWH 技術直接解決了以前無法採用大氣水解決方案的挑戰,特別是提供大幅改進的操作性能,包括能源效率,無相對濕度依賴性以及可靠的產量。迄今為止,Healixa 已經收到了超過 75,000,000 美元的訂單指示。
"Healixa has achieved the latest milestone in its multi-year R&D and commercialization program for its unique Global AquaDuct AWH solution having exceeded all our internal development requirements and reaching the Minimum Viable Product (MVP) stage. As we quickly advance our commercialization efforts in 2023, we are especially excited to demonstrate Global AquaDuct MVP to select end users," commented Ian Parker, Chairman and CEO of Healixa. "On behalf of our management team, directors and advisory board, we wish to acknowledge the outstanding work and dedication of our engineering teams and manufacturing partners who supported us and look forward to doing our part to help address the growing global water scarcity crisis."
Healixa 憑藉其獨特的全球 AquaDaduct AWH 解決方案,在其多年的研發和商業化計劃中取得了最新的里程碑,已經超越了我們所有的內部開發要求,並達到了最低可行產品(MVP)階段。隨著我們在 2023 年迅速推進商業化工作,我們特別高興能夠向全球 AquADCt MVP 選擇最終用戶。」代表我們的管理團隊、董事和諮詢委員會,我們希望感謝我們的工程團隊和製造合作夥伴的傑出工作和奉獻精神,他們為我們提供支持,並期待盡我們的一份力量來幫助解決日益嚴重的全球水資源短缺危機。」
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧